PowerUp Acquisition Corp.
NASDAQ Global MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Surendra K. Ajjarapu
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 188 Grand Street New York City NY United States of America 10013
- IPO Date
- Apr 11, 2022
- CIK
- 0001847345
- Similar Companies
- Business
- PowerUp Acquisition Corp., initially formed as a special purpose acquisition company in New York during 2021, had aimed to achieve a business combination, such as a merger or asset acquisition, within the interactive and digital media, sports, entertainment, or leisure industries, specifically targeting the video gaming and metaverse segments. However, the entity successfully completed its strategic merger on February 17, 2025, by combining with Aspire Biopharma, Inc. The unified company is now known as Aspire Biopharma Holdings, Inc., and its common stock began trading on Nasdaq under the ticker symbol ASBP on February 20, 2025. This newly established biopharmaceutical firm is focused on developing and commercializing groundbreaking drug delivery technologies for FDA-approved medications, nutraceuticals, and dietary supplements, highlighted by its key product, Instaprin, a fast-acting aspirin formulation.
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers of PWUP and ESGR
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers of PWUP, ESGR
Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements
Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.
PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders